批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/08/22 |
SUPPL-88(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2022/08/22 |
SUPPL-87(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2021/08/09 |
SUPPL-86(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2020/01/02 |
SUPPL-85(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2019/07/15 |
SUPPL-83(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2019/04/05 |
SUPPL-84(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2018/05/23 |
SUPPL-80(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2018/01/12 |
SUPPL-81(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2017/04/11 |
SUPPL-76(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2015/11/05 |
SUPPL-75(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2015/05/28 |
SUPPL-73(补充) |
Approval |
Efficacy |
PRIORITY
;Orphan
|
|
|
2015/03/30 |
SUPPL-72(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/03/06 |
SUPPL-74(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/07/03 |
SUPPL-71(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/01/29 |
SUPPL-70(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/11/06 |
SUPPL-69(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/05/30 |
SUPPL-68(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/03/07 |
SUPPL-67(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/12/10 |
SUPPL-65(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/07/11 |
SUPPL-59(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/06/06 |
SUPPL-60(补充) |
Approval |
REMS |
N/A
|
|
|
2010/11/23 |
SUPPL-57(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2010/11/23 |
SUPPL-55(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/11/08 |
SUPPL-58(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/07/02 |
SUPPL-56(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/04/22 |
SUPPL-54(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/04/22 |
SUPPL-53(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/01/25 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2009/10/08 |
SUPPL-51(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2009/09/24 |
SUPPL-50(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/01/29 |
SUPPL-49(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/03/05 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/03/05 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/01/14 |
SUPPL-43(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2007/10/17 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/05/02 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/01/30 |
SUPPL-37(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2007/01/12 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/01/09 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/10/19 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/06/02 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/06/02 |
SUPPL-32(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2006/03/10 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2005/10/07 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/10/07 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/06/30 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/06/30 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/03/11 |
SUPPL-24(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2004/07/20 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/02/23 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2003/10/02 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/04/11 |
SUPPL-4(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2003/03/19 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/03/19 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/01/31 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/01/23 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/01/23 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/01/23 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/01/23 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/01/23 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2002/08/22 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/06/05 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/05/07 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/09/06 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/08/25 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
;Orphan
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:SIROLIMUS 剂型/给药途径:TABLET;ORAL 规格:1MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021110 |
001 |
NDA |
RAPAMUNE |
SIROLIMUS |
TABLET;ORAL |
1MG |
Prescription |
Yes |
No |
AB |
2000/08/25
|
PF PRISM CV |
201578 |
001 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
1MG |
Prescription |
No |
No |
AB |
2014/10/27
|
DR REDDYS |
208691 |
002 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
1MG |
Prescription |
No |
No |
AB |
2020/10/16
|
GLENMARK PHARMS LTD |
214753 |
002 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
1MG |
Prescription |
No |
No |
AB |
2021/03/12
|
ALKEM LABS LTD |
201676 |
001 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
1MG |
Prescription |
No |
No |
AB |
2023/02/15
|
ZYDUS PHARMS |
活性成分:SIROLIMUS 剂型/给药途径:TABLET;ORAL 规格:2MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021110 |
002 |
NDA |
RAPAMUNE |
SIROLIMUS |
TABLET;ORAL |
2MG |
Prescription |
Yes |
Yes |
AB |
2002/08/22
|
PF PRISM CV |
201578 |
002 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
2MG |
Prescription |
No |
No |
AB |
2014/10/27
|
DR REDDYS |
208691 |
003 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
2MG |
Prescription |
No |
No |
AB |
2020/10/16
|
GLENMARK PHARMS LTD |
214753 |
003 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
2MG |
Prescription |
No |
No |
AB |
2021/03/12
|
ALKEM LABS LTD |
201676 |
002 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
2MG |
Prescription |
No |
No |
AB |
2023/02/15
|
ZYDUS PHARMS |
活性成分:SIROLIMUS 剂型/给药途径:TABLET;ORAL 规格:0.5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021110 |
004 |
NDA |
RAPAMUNE |
SIROLIMUS |
TABLET;ORAL |
0.5MG |
Prescription |
Yes |
No |
AB |
2010/01/25
|
PF PRISM CV |
201676 |
003 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
0.5MG |
Prescription |
No |
No |
AB |
2014/01/08
|
ZYDUS PHARMS |
208691 |
001 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
0.5MG |
Prescription |
No |
No |
AB |
2020/10/16
|
GLENMARK PHARMS LTD |
214753 |
001 |
ANDA |
SIROLIMUS |
SIROLIMUS |
TABLET;ORAL |
0.5MG |
Prescription |
No |
No |
AB |
2021/03/12
|
ALKEM LABS LTD |